Generic placeholder image

Current Pharmaceutical Design


ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Role of Nicotinic and Muscarinic Receptors on Synaptic Plasticity and Neurological Diseases

Author(s): Marco Fuenzalida, Miguel Ángel Pérez and Hugo R. Arias

Volume 22, Issue 14, 2016

Page: [2004 - 2014] Pages: 11

DOI: 10.2174/1381612822666160127112021

Price: $65


The cholinergic activity in the brain is fundamental for cognitive functions. The modulatory activity of the neurotransmitter acetylcholine (ACh) is mediated by activating a variety of nicotinic acetylcholine receptors (nAChR) and muscarinic acetylcholine receptors (mAChR). Accumulating evidence indicates that both nAChR and mAChRs can modulate the release of several other neurotransmitters, modify the threshold of long-term plasticity, finally improving learning and memory processes. Importantly, the expression, distribution, and/or function of these systems are altered in several neurological diseases. The aim of this review is to discuss our current knowledge on cholinergic receptors and their regulating synaptic functions and neuronal network activities as well as their use as targets for the development of new and clinically useful cholinergic ligands. These new therapies involve the development of novel and more selective cholinergic agonists and allosteric modulators as well as selective cholinesterase inhibitors, which may improve cognitive and behavioral symptoms, and also provide neuroprotection in several brain diseases. The review will focus on two nAChR receptor subtypes found in the mammalian brain and the most commonly targeted in drug discovery programs for neuropsychiatric disorder, the ligands of α4β2 nAChR and α7 nAChRs.

Keywords: Acetylcholine, nicotinic receptors, muscarinic receptors, synaptic plasticity, neurological disease.

Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy